IPP Bureau
Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%
By IPP Bureau - July 10, 2024
The approved ANDA is therapeutically equivalent to the reference listed drug product
Lilly to acquire Morphic to improve outcomes for patients with inflammatory bowel disease
By IPP Bureau - July 10, 2024
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Synexa Life Sciences enrolls in My Green Lab Certification Program
By IPP Bureau - July 10, 2024
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Surfix Diagnostics, NKI and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening
By IPP Bureau - July 10, 2024
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets
By IPP Bureau - July 10, 2024
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Zydus receives tentative approval from USFDA for Diroximel Fumarate DR Capsules
By IPP Bureau - July 10, 2024
Diroximel Fumarate Delayed-Release Capsules is indicated for the treatment of relapsing forms of multiple sclerosis
Lupin receives tentative approval from USFDA for Empagliflozin, Linagliptin and Metformin Hydrochloride ER tablets
By IPP Bureau - July 10, 2024
This product will be manufactured at Lupin’s Pithampur facility in India
Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution
By IPP Bureau - July 10, 2024
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
AbbVie appoints Roopal Thakkar as EVP, Research & Development and Chief Scientific Officer
By IPP Bureau - July 10, 2024
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Olverembatinib approved for commercialization in Macau China
By IPP Bureau - July 09, 2024
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Biostar Pharma gets FDA clearance of the IND application for a Phase 2 study of Utidelone Injection
By IPP Bureau - July 09, 2024
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Ligand to acquire Apeiron Biologics for US$100 million
By IPP Bureau - July 09, 2024
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Olink announces receipt of CMA clearance for proposed acquisition by Thermo Fisher
By IPP Bureau - July 09, 2024
Shares and American Depositary Shares of Olink for $26.00 per Share
Health Minister Nadda visits the AIIMS Jammu
By IPP Bureau - July 08, 2024
AIIMS Jammu is a beacon of hope not only for the people of J&K, but also for that of Leh, and other neighboring states
Increasing public awareness on World Zoonoses Day
By IPP Bureau - July 08, 2024
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
